I agree that this site is using cookies. You can find further informations here.
X
Buadi, F
107  results:
Search for persons X
?
1

Correction: Outcomes among newly diagnosed AL amyloidosis p..:

Vaxman, I. ; Kumar, S. K. ; Buadi, F....
Leukemia.  38 (2024)  8 - p. 1866-1866 , 2024
Link: https://doi.org/10.1038/..
 
?
2

Daratumumab, carfilzomib, and pomalidomide for the treatmen..:

Vaxman, I. ; Kumar, S. K. ; Buadi, F....
Blood Cancer Journal.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
3

P966: DARATUMUMAB, CARFILZOMIB, POMALIDOMIDE AND ELOTUZUMAB..:

Vaxman, I. ; Kumar, S. ; buadi, F....
HemaSphere.  6 (2022)  - p. 856-857 , 2022
Link: https://doi.org/10.1097/..
 
?
4

P884: POTENTIAL BENEFIT OF POST-TRANSPLANT DOXYCYCLINE IN A..:

Abdallah, N. ; Dispenzieri, A. ; Muchtar, E....
HemaSphere.  6 (2022)  - p. 776-777 , 2022
Link: https://doi.org/10.1097/..
 
?
5

Outcomes among newly diagnosed AL amyloidosis patients with..:

Vaxman, I. ; Kumar, S. K. ; Buadi, F....
Leukemia.  35 (2021)  12 - p. 3604-3607 , 2021
Link: https://doi.org/10.1038/..
 
?
6

"Real-life" data of the efficacy and safety of belantamab m..:

Vaxman, I. ; Abeykoon, J. ; Dispenzieri, A....
Blood Cancer Journal.  11 (2021)  12 - p. , 2021
Link: https://doi.org/10.1038/..
 
?
7

INFLAMMATORY MYOPATHIES:

Naddaf, E. ; Milone, M. ; Kansagra, A...
Neuromuscular Disorders.  28 (2018)  - p. S78 , 2018
Link: https://doi.org/10.1016/..
 
?
8

Phase I trial of systemic administration of Edmonston strai..:

Dispenzieri, A ; Tong, C ; LaPlant, B...
Leukemia.  31 (2017)  12 - p. 2791-2798 , 2017
Link: https://doi.org/10.1038/..
 
?
9

A phase 1 trial of 90Y-Zevalin radioimmunotherapy with auto..:

Dispenzieri, A ; D'Souza, A ; Gertz, M A...
Bone Marrow Transplantation.  52 (2017)  10 - p. 1372-1377 , 2017
Link: https://doi.org/10.1038/..
 
?
10

Changes in uninvolved immunoglobulins during induction ther..:

Ravi, P ; Kumar, S ; Gonsalves, W...
Blood Cancer Journal.  7 (2017)  6 - p. e569-e569 , 2017
Link: https://doi.org/10.1038/..
 
?
11

Evolving changes in disease biomarkers and risk of early pr..:

Ravi, P ; Kumar, S ; Larsen, J T...
Blood Cancer Journal.  6 (2016)  7 - p. e454-e454 , 2016
Link: https://doi.org/10.1038/..
 
?
12

Positron emission tomography-computed tomography in the dia..:

Siontis, B ; Kumar, S ; Dispenzieri, A...
Blood Cancer Journal.  5 (2015)  10 - p. e364-e364 , 2015
Link: https://doi.org/10.1038/..
 
?
13

A simple model to predict survival using age, comorbidities..:

Milani, P. ; Buadi, F. ; Gertz, M....
Clinical Lymphoma Myeloma and Leukemia.  15 (2015)  - p. e94-e95 , 2015
Link: https://doi.org/10.1016/..
 
?
14

Characteristics of exceptional responders to lenalidomide-b..:

Vu, T ; Gonsalves, W ; Kumar, S...
Blood Cancer Journal.  5 (2015)  10 - p. e363-e363 , 2015
Link: https://doi.org/10.1038/..
 
?
15

Phase II Trial of Intravenously Administered AMD3100 (Pleri..:

Kumar, S. ; Mikhael, J. ; Lacy, M....
Biology of Blood and Marrow Transplantation.  18 (2012)  2 - p. S247 , 2012
Link: https://doi.org/10.1016/..
 
1-15